Public-domain · open source
OpenJurist
← 432 FSUPP2D 964 - Jackson v. Pfizer, Inc.

Jackson v. Pfizer, Inc.’s Empirical Analysis

2006

Citation profile

9
cited by 9 later decisions
1
cited 1 times by the Supreme Court
2
states following
April 2009
most recently cited

1 district · 2 state decisions

Relationships

Applies 21 U.S.C. § 355 (Federal Food, Drug, and Cosmetic Act)

Relies on Cipollone v. Liggett Group, Inc. · Medtronic, Inc. v. Lohr · Crosby Secretary of Administration and Finance of Massachusetts v. National Foreign Trade Council · Cts Corporation v. Dynamics Corporation of America Indiana · Cliff v. Payco General American Credits, Inc.

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 9 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “The FDA failed to comply with its requirements to communicate with the states and to allow the states an opportunity to participate in the proceedings prior to a preemption decision.”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.